Thursday, March 4, 2021
12:23 AM
Reuters/Geneva
The World Health Organization said on Wednesday it had received data from Pfizer and BioNTech on the Covid-19 vaccine and was reviewing it for "possible listing for emergency use", a benchmark for countries to authorise national use.
Referring to Britain's regulator, the Medicines and Healthcare products Regulatory Agency, it said in a statement to Reuters: "WHO is also in discussions with MHRA on the possibility of accessing some of the information from their assessment, which could expedite WHO’s emergency listing".
Britain approved Pfizer's Covid-19 vaccine on Wednesday, jumping ahead of the United States and Europe to become the West's first country to formally endorse a shot it said should reach the most vulnerable people early next week.
Mike Ryan, WHO's top emergency expert, welcomed the news, adding: "We shouldn't stop, we need more than 3-4 vaccines
"We need to increase production, we need to pull the price down," he told a social media event. "We need a one-dose vaccine."
Covax details rollout of 238mn vaccine doses
Ex-president Sarkozy is convicted of corruption
UK hunts for carrier of Brazil Covid strain
Waiver war at WTO over Covid jab IP rights
Russia launches satellite to monitor climate in Arctic
Finnish team cuts giant ‘ice carousel’
UK says farewell to Captain Tom Moore
Roman chariot unearthed ‘almost intact’ near Pompeii
Armenian president blocks PM’s bid to sack armed forces chief
3/3/2021 11:32:05 PM
3/3/2021 10:58:26 PM
3/3/2021 10:25:02 PM
There are no comments.